Klinične študije za Migrena v Kalifornija
18 študij za Migrena išče udeležence na lokacijah v Kalifornija.
Mesta v Kalifornija
- Concord8 študij
- San Diego6 študij
- Fresno5 študij
- Los Angeles4 študij
- Pomona4 študij
- Long Beach4 študij
- Anaheim4 študij
- Oceanside3 študij
Uradno besedilo študije (angleško)
Study of EVO756 in Adults With Migraine
- Buena Park Research Center, Buena Park
- Neuro Pain Research Center, Fresno
- CA Medical Clinic for Headache, Los Angeles
- in še 1
Vključevanje udeležencevFaza 2
Starost 18–64 · Vsi spoli · Posodobljeno 2. okt. 2026 · NCT07616128Efficacy and Safety Study of Rimegepant for the Preventative Treatment of Migraine in Pediatric Subjects
- Advanced Investigative Medicine, Inc., Hawthorne
Vključevanje udeležencevFaza 3
Starost 6–17 · Vsi spoli · Posodobljeno 28. sep. 2026 · NCT05156398MMA Embolization for Refractory Chronic Migraine
- John Muir Physician Network Clin. Research Center, Walnut Creek
Vključevanje udeležencev
Starost 18–65 · Vsi spoli · Posodobljeno 25. sep. 2026 · NCT06735833Long-term Safety Study of Rimegepant in Pediatric Subjects for the Acute Treatment of Migraine
- Advanced Research Center, Inc., Anaheim
- Neuro-Pain Research Center, Fresno
- Altman Clinical and Translational Research Institute, University of California San Diego, La Jolla
- in še 4
Vključevanje udeležencevFaza 3
Starost 6–17 · Vsi spoli · Posodobljeno 24. sep. 2026 · NCT04743141Randomized Study in Children and Adolescents With Migraine: Acute Treatment
- Advanced Research Center, Inc., Anaheim
- Adult & Child Neurology Medical Associates, Costa Mesa
- Memorial Health Services, Fountain Valley
- in še 9
Vključevanje udeležencevFaza 3
Starost 6–17 · Vsi spoli · Posodobljeno 24. sep. 2026 · NCT04649242A Study of Oral Atogepant Tablets to Assess Adverse Events and Change in Disease Activity To Prevent Migraine in Participants Aged 12 to 17 Years
- Advanced Research Center /ID# 270257, Anaheim
- Neuro Pain Research Center /ID# 271048, Fresno
- Accellacare - Long Beach /ID# 270398, Long Beach
- in še 3
Vključevanje udeležencevFaza 3
Starost 12–17 · Vsi spoli · Posodobljeno 22. sep. 2026 · NCT06810505Responding With Evidence and Access for Childhood Headaches
- University of California San Francisco, San Francisco
Vključevanje udeležencev
Starost 10–17 · Vsi spoli · Posodobljeno 21. sep. 2026 · NCT05889624Comparative Effectiveness of Migraine Preventive Medications: The APT Comparison Study
- Keck School of Medicine of USC, Los Angeles
- Clinical Research Institute, Los Angeles
- Desert Physicians Medical Group, Palm Springs
- in še 1
Vključevanje udeležencevFaza 4
Starost 18–70 · Vsi spoli · Posodobljeno 16. sep. 2026 · NCT06972056Study to Assess Adverse Events and Disease Activity of Oral Ubrogepant Tablets for the Acute Treatment of Migraine in Children and Adolescents (Ages 6-17)
- Advanced Research Center /ID# 227962, Anaheim
- Neuro Pain Research Center /ID# 227966, Fresno
- Imax Clinical Trials /ID# 281436, La Palma
- in še 7
Vključevanje udeležencevFaza 3
Starost 6–17 · Vsi spoli · Posodobljeno 14. sep. 2026 · NCT05125302Study Evaluating the Efficacy, Safety, and Tolerability of ASY202 (Dihydroergotamine Mesylate [DHE] Inhalation Powder Delivered Via a Multidose Dry Powder Inhaler) for the Acute Treatment of Migraine in Adult Patients
- Sunwise Clinical Research, Llc, Walnut Creek
Vključevanje udeležencevFaza 2
Starost 18–65 · Vsi spoli · Posodobljeno 2. sep. 2026 · NCT07646613A Study to Evaluate the Efficacy and Safety of Elismetrep (K-304) in the Acute Treatment of Migraine
- Axiom Research, LLC, Colton
- ProScience Research Group, Culver City
- Leading Edge Research LA, LLC, Encino
- in še 15
Vključevanje udeležencevFaza 3
Starost 18–75 · Vsi spoli · Posodobljeno 20. avg. 2026 · NCT07645924Emgality for Migraine in Breastmilk
- University of California, San Francisco, San Francisco
Vključevanje udeležencevOpazovalna študija
Starost 18–45 · Ženske · Posodobljeno 11. avg. 2026 · NCT06085144Treatment of Meniere's Disease With Migraine Medications
- University of California, Irvine Medical Center ENT Clinic (Pavilion 2), Orange
Vključevanje udeležencevFaza 4
Starost 25–85 · Vsi spoli · Posodobljeno 22. jun. 2026 · NCT05582837A Study to Investigate the Safety and Efficacy of MEDI0618 Compared to Placebo in Adult Participants With Episodic Migraine
- The Neurology Center of Southern California - Carlsbad Office, La Jolla
- Clinical Research Institute, LCC, Los Angeles
Vključevanje udeležencevFaza 2
Starost 18–70 · Vsi spoli · Posodobljeno 19. maj 2026 · NCT06602479Clinical Trial of Endoscopically Guided Injection of Exparel (Bupivacaine) for the Treatment of Craniofacial Pain
- Peter H Hwang, Stanford
Vključevanje udeležencevFaza 2
Starost 18–80 · Vsi spoli · Posodobljeno 27. apr. 2026 · NCT04930887Study to Assess the Real-World Effectiveness of Ubrogepant in Adult Participants When Treating During the Prodrome Phase of Migraine Attacks
- Neurology and Pain Specialty Center /ID# 278508, Aliso Viejo
Vključevanje udeležencevOpazovalna študija
Starost 18 in več · Vsi spoli · Posodobljeno 10. feb. 2026 · NCT07310290Analysis of Headache Chronification With Imaging, Deep Phenotyping, and Proteomics
- Stanford University School of Medicine, Stanford
Vključevanje udeležencevOpazovalna študijaVabljeni zdravi prostovoljci
Starost 18 in več · Vsi spoli · Posodobljeno 23. jul. 2025 · NCT03231241Qudexy XR for the Prevention of Migraine in Children 6 to 11 Years Old
- Upsher-Smith Clinical Trial Site #15, La Jolla
Vključevanje udeležencevFaza 4
Starost 6–11 · Vsi spoli · Posodobljeno 27. jan. 2025 · NCT04748601Vir: ClinicalTrials.gov, podatki pridobljeni 5. okt. 2026. Vsaka študija ima svoje pogoje vključitve; ekipa študije odloči, kdo lahko sodeluje.